Enriace Medical Supply Corpora Miami, FL - 33172

Enriace Medical Supply Corpora is categorized under Medical Apparatus and Supplies in Miami, FL and active since 2007.

Enriace Medical Supply Corpora was established in 2007, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 446199 by the NAICS.

If you are seeking more information, feel free to contact Saul Lopez at the company’s single location by writing to 175 Fontainebleau Boulevard, Miami, Florida FL 33172 or by phoning (305) 229-0025. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Enriace Medical Supply Corpora
Contact Person: Saul Lopez
Address: 175 Fontainebleau Boulevard, Miami, Florida 33172
Phone Number: (305) 229-0025
Annual Revenue (USD): $50.000 to $99.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Apparatus and Supplies
SIC Code: 5999
NAICS Code: 446199
Share This Business:

Enriace Medical Supply Corpora was started in 2007 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 446199. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Saul Lopez for inquiries that concern Enriace Medical Supply Corpora by calling the company number (305) 229-0025, as your correspondence is most welcome. Additionally, the physical location of the single location of Enriace Medical Supply Corpora can be found at the coordinates 25.77077,-80.338835 as well as the street address 175 Fontainebleau Boulevard in Miami, Florida 33172.

For its online presence, you may visit Enriace Medical Supply Corpora’s website at and engage with its social media outlets through on Twitter and on Facebook.